Wednesday, April 06, 2022 8:43:19 AM
We still have 15k shares of VCEL with cost basis of $3.32. We surely are not down 96.2% from all time high; rather we are up 1066.85% at close of $38.75.
Assuming VCEL gets the NexoBrid approval this year, I can see your 1066.85% becoming 5000% by end 2023. Not kidding here, all VCEL products are basically without competition and without generic pathways.
What do you see re direction of market the rest of year, AMRN in particular?
I only have a small position in AMRN........ its prospects seem murky to me, they don't seem to have stemmed generic erosion in the USA, and its always the USA that gets reflected in price.... of course PFE signing on for Canadian sales suggests interest. As for the market, who knows, but one would think recovery to some norm is inevitable. The most clear winners like VCEL should lead.
Assuming VCEL gets the NexoBrid approval this year, I can see your 1066.85% becoming 5000% by end 2023. Not kidding here, all VCEL products are basically without competition and without generic pathways.
What do you see re direction of market the rest of year, AMRN in particular?
I only have a small position in AMRN........ its prospects seem murky to me, they don't seem to have stemmed generic erosion in the USA, and its always the USA that gets reflected in price.... of course PFE signing on for Canadian sales suggests interest. As for the market, who knows, but one would think recovery to some norm is inevitable. The most clear winners like VCEL should lead.
Recent VCEL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 08:05:42 PM
- Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid • GlobeNewswire Inc. • 04/02/2026 06:40:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 06:28:38 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/01/2026 11:50:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 08:05:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 08:05:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/23/2026 08:08:21 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/19/2026 11:31:10 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/19/2026 11:30:37 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/19/2026 11:30:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:05:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:05:19 PM
- Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- Vericel to Present at Multiple Upcoming Investor Conferences • GlobeNewswire Inc. • 03/03/2026 01:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 09:54:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 09:21:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 09:05:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 09:05:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 09:05:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 09:05:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 09:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 09:05:30 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 02:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:02:06 PM
- Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results • GlobeNewswire Inc. • 02/26/2026 12:55:00 PM
